1 – 11 of 11
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cognitive Safety is Largely Ignored in Clinical Drug Trials : A Study of Registered Study Protocols
(
- Contribution to journal › Article
- 2021
-
Mark
Widespread skeptic attitudes among people with epilepsy toward generic antiseizure drugs – A Swedish survey study
(
- Contribution to journal › Article
-
Mark
Rash during lamotrigine treatment is not always drug hypersensitivity a retrospective cohort study among children and adults
(
- Contribution to journal › Article
- 2019
-
Mark
Lamotrigine, bipolar disorder, and the pill-free week
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy
(
- Contribution to journal › Article
-
Mark
The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders
(
- Contribution to journal › Scientific review
-
Mark
Quality of life after switching to generic levetiracetam – A prospective comparative study
(
- Contribution to journal › Article
- 2018
-
Mark
Skal gravide ha lavere eller høyere legemiddeldoser?
(
- Contribution to journal › Article
-
Mark
Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs : Focus on Topiramate, Levetiracetam, and Perampanel
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Impact of generic substitution on levetiracetam serum concentration : A prospective study in an outpatient setting
(
- Contribution to journal › Article
-
Mark
Impact of generic substitution on levetiracetam serum concentration - a prospective study in an outpatient setting
2017) 2017 American Epilepsy Society (AES) Annual Meeting(
- Contribution to conference › Abstract